Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2005
08/30/2005US6936606 Cyanoamido-containing heterocyclic compounds useful as reversible inhibitors of cysteine proteases
08/30/2005US6936604 Treating hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema and ischemia, stroke, thrombosis and water retention
08/30/2005US6936600 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents
08/30/2005US6936597 A conjugate of blocked polymer with a biologically active compound containing reactive hydroxy or amino groups
08/30/2005US6936595 Tumour-specific vector for gene therapy
08/30/2005US6936594 Gene therapy for cerebrovascular disorders
08/30/2005US6936282 Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
08/30/2005US6936258 Staphylococcus antigen and vaccine
08/30/2005US6935334 Enhancing therapeutic effectiveness of nitric oxide inhalation
08/30/2005CA2336968C Quinoline derivatives
08/30/2005CA2133152C Piperidines and piperazines with affinity for 5-ht receptors
08/30/2005CA2103887C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
08/25/2005WO2005077912A1 Indazole compound and pharmaceutical use thereof
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077887A1 Novel method of synthesis and novel crystalline form of agomelatine and pharmaceutical compositions containing said form
08/25/2005WO2005077400A1 Cysteine rich peptides for improving thiol homeostasis
08/25/2005WO2005077395A1 Physiologically active composition and process for producing the same
08/25/2005WO2005077359A1 Stabilized pharmaceutical composition containing indoline compound
08/25/2005WO2005062824A3 Anti-hypercholesterolemic compounds
08/25/2005US20050187294 With lipoxin analog inhibitors of polyisoprenyl phosphate signaling; treating diseases associated with phospholipase D (PLD) initiated polymorphoneutrophil (PMN) inflammation
08/25/2005US20050187282 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands
08/25/2005US20050187275 Preterm labor, premature birth, dysmenorrhea, inappropriate secretion of vasopressin, congestive heart failure, arterial hypertension, liver cirrhosis, nephrotic syndrome and ocular hypertension; 3-(5-((3-chlorobenzyl)sulfanyl)-4-(3-methoxypropyl)-4H-1,2,4-triazol-3-yl)-N-(2-methoxybenzyl)propanamide
08/25/2005US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
08/25/2005US20050187269 Benzimidazole derivative and use thereof
08/25/2005US20050187257 Methods of treating sepsis
08/25/2005US20050187236 Nitrogen-containing aromatic derivatives
08/25/2005US20050187226 A1 adenosine receptor antagonists
08/25/2005US20050187220 Alleviating pain, treating a locomotive disorders, stress, depression, epilepsy, Alzheimer's disease, senile dementia, general cognitive dysfunction, drug and alcohol abuse, hypotension, hypertension, tinnitus, pruritus, defective hearing, anorexia, obesity; chemical synthesis
08/25/2005US20050187210 Method for treating severe heart failure and medicament therefor
08/25/2005US20050187205 Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
08/25/2005US20050187194 fructose 1,6-bisphosphatase (FBPase) inhibitors for diabetic complications, hyperlipidemia, hypertension, arteriosclerosis, macroangiopathy; 2-amino-5-isobutyl-4-{2-[5-(N,N'-bis((S)-1-ethoxycarbonyl)ethyl)phosphonamido]furanyl}thiazole
08/25/2005US20050186665 Expressed ligand - vascular intercellular signaling molecule
08/25/2005US20050186663 Cystine-knot fold protein
08/25/2005US20050186650 Pharmaceuticals and methods for treating hypoxia and screening methods therefor
08/25/2005US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity
08/25/2005US20050186567 Antisense modulation of peroxisome proliferator-activated receptor gamma expression
08/25/2005US20050186279 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
08/25/2005US20050186265 Negatively charged first lipid; barium, calcium, zinc, magnesium and/or cation; carbohydrates, vitamins, minerals, polynucleotides, polypeptides, lipids, flavors and drugs; particle sizes; storage stability, oxidation resistance, dimensional stability;
08/25/2005US20050186250 Metallic structures incorporating bioactive materials and methods for creating the same
08/25/2005US20050186198 Serine protease inhibitors
08/25/2005DE29924789U1 New, stable crystalline polymorph (form III) of the diuretic torasemide, by controlled acidification of alkaline solutions, has more rapid dissolution than form I
08/25/2005CA2556601A1 The use of o-atp for the treatment of diseases involving angiogenesis
08/25/2005CA2556404A1 Nitrogenous fused heteroaromatic ring derivative
08/25/2005CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins
08/25/2005CA2555142A1 Cell proliferation associated with ccx ckr expression
08/25/2005CA2554996A1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases
08/25/2005CA2554378A1 Bicycloamide derivative
08/25/2005CA2549954A1 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics
08/24/2005EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
08/24/2005EP1566380A1 Isoquinoline compounds and medicinal use thereof
08/24/2005EP1566181A1 Novel medicament for ameliorating neurotransmission dysfunction diseases
08/24/2005EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use
08/24/2005EP1565491A2 Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition of angiogenesis
08/24/2005EP1565485A1 Perindopril
08/24/2005EP1565474A2 Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
08/24/2005EP1565472A2 Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
08/24/2005EP1565467A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
08/24/2005EP1565463A1 Imidazo[1,5a]pyridine derivatives and methods for treating aldosterone mediated diseases
08/24/2005EP1565459A2 Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors
08/24/2005EP1565452A2 3-substituted-6-aryl pyridines as ligands of c5a receptors
08/24/2005EP1565239A2 Liquid pharmaceutical formulations containing 3,7-diazabicyclo'3,3,1! nonanes for treating anti-arrhythmic events
08/24/2005EP1565230A2 Material compositions and related systems and methods for treating cardiac conditions
08/24/2005EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1565177A1 Use of pharmaceutical compositions containing ethyl esters of omega-3 polyunsaturated acids to prevent atrial fibrillation
08/24/2005EP1565174A1 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function
08/24/2005EP1565171A2 Controlled absorption of mixed thyroyd hormone formulations
08/24/2005EP1468003B1 Phosphinic pseudo-peptide derivatives
08/24/2005EP1458713B1 Indolinone derivatives useful as protein kinase inhibitors
08/24/2005EP1401841B1 Substituted 1-oxa-2,8-diaza-spiro 4,5]dec-2-ene derivatives as medicaments for the treatment of pain
08/24/2005EP1392307B1 Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene
08/24/2005EP1360185B1 Carboline derivatives
08/24/2005EP1353927B1 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors
08/24/2005EP1353912B1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
08/24/2005EP1343789B1 Tricyclic derivatives of indole with antiangiogenic activity
08/24/2005EP1335917B1 Condensed pyridoindole derivatives
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/24/2005EP1286975B1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
08/24/2005EP1280779B1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
08/24/2005EP1272505B1 8beta-substituted-11beta-pentyl- and 11beta-hexyl-estra-1,3,5(10)-triene derivatives
08/24/2005EP1218341B1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
08/24/2005EP1216246B1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent
08/24/2005EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
08/24/2005EP1169025B1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
08/24/2005EP1144394B1 1-heterocycle substituted diarylamines
08/24/2005EP1131301B1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways
08/24/2005EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4
08/24/2005CN1659182A Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
08/24/2005CN1659180A Novel recombinant anticoagulant proteins
08/24/2005CN1659171A Specific cyclolignans for treating insulin-like growth factor-1 receptor dependent diseases
08/24/2005CN1659169A Riboflavin derivative and its preparation method and uses
08/24/2005CN1659166A 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
08/24/2005CN1659165A Quinolinone derivatives
08/24/2005CN1659164A Benzoxazinone-derived compounds, their preparation and use as medicaments
08/24/2005CN1659163A Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis
08/24/2005CN1659162A Tricyclic thrombin receptor antagonists
1 ... 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 ... 1595